Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in Children
- PMID: 27043788
- DOI: 10.1001/jamapediatrics.2016.0033
Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in Children
Abstract
Importance: The diagnostic properties of a graded provocation challenge (PC) among children presenting with a rash in the course of amoxicillin treatment are currently unknown.
Objective: To assess the accuracy and the negative predictive value of the PC in a cohort of children referred with suspected allergy to amoxicillin.
Design, setting, and participants: A cohort study was conducted between March 1, 2012, and April 1, 2015, at the allergy clinic of the Montreal Children's Hospital, Montreal, Quebec, Canada. All children referred with suspected allergy to amoxicillin were approached. In addition, 346 eligible children were followed up to assess reactions to subsequent use of amoxicillin at the time of illness in cases with negative PC results. Data were collected on clinical characteristics, suspected antibiotic exposure, personal and first-degree relatives' comorbidities, and history of atopy and management of the reaction. Univariate and multivariate logistic regressions were compared to determine factors associated with immediate and nonimmediate reactions to the PC.
Interventions: All children had a graded PC.
Main outcomes and measures: Reactions to the graded PC, the negative predictive value of the PC for nonimmediate reactions, and factors associated with immediate and nonimmediate reactions to the PC.
Results: A total of 818 children were assessed (median age, 1.7 years [interquartile range, 1.0-3.9 years]; 441 [53.9%] male). Among all participants, 770 (94.1%) tolerated the PC, 17 (2.1%) developed mild immediate reactions, and 31 (3.8%) developed nonimmediate reactions. The graded PC had a specificity of 100.0% (95% CI, 90.9%-100.0%), a negative predictive value of 89.1% (95% CI, 77.1%-95.5%), and a positive predictive value of 100.0% (95% CI, 86.3%-100.0%). Among all 346 participants eligible for annual follow-up, 250 (72.3%; 95% CI, 67.2%-76.8%) responded, 55 of whom received subsequent full treatment with amoxicillin; 49 of these 55 participants (89.1%) reported tolerance to subsequent full treatment with amoxicillin, while 6 (10.9%) developed nonimmediate cutaneous reactions. History of a reaction occurring within 5 minutes of exposure was associated with immediate reactions to the PC (adjusted odds ratio = 9.6; 95% CI, 1.5-64.0), while a rash that lasted longer than 7 days (adjusted odds ratio = 4.8; 95% CI, 1.4-16.4) and parental history of drug allergy (adjusted odds ratio = 3.0; 95% CI, 1.3-6.8) were associated with nonimmediate reactions to the PC.
Conclusions and relevance: Graded PCs provide an accurate and safe confirmatory test for skin-related reactions to amoxicillin. Further studies are required to assess factors associated with the PC outcome groups.
Comment in
-
Provocation Challenges to Evaluate Amoxicillin Allergy in Children.JAMA Pediatr. 2016 Jun 6;170(6):e160282. doi: 10.1001/jamapediatrics.2016.0282. Epub 2016 Jun 6. JAMA Pediatr. 2016. PMID: 27043299 No abstract available.
Similar articles
-
Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions.J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):375-80.e1. doi: 10.1016/j.jaip.2014.11.001. Epub 2015 Jan 16. J Allergy Clin Immunol Pract. 2015. PMID: 25609343
-
Establishing Amoxicillin Allergy in Children Through Direct Graded Oral Challenge (GOC): Evaluating Risk Factors for Positive Challenges, Safety, and Risk of Cross-Reactivity to Cephalosporines.J Allergy Clin Immunol Pract. 2021 Nov;9(11):4060-4066. doi: 10.1016/j.jaip.2021.06.057. Epub 2021 Jul 19. J Allergy Clin Immunol Pract. 2021. PMID: 34293504
-
Asthma, Family History of Drug Allergy, and Age Predict Amoxicillin Allergy in Children.J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1363-1367. doi: 10.1016/j.jaip.2017.11.015. Epub 2017 Dec 7. J Allergy Clin Immunol Pract. 2018. PMID: 29226807
-
Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis.J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):3-12. doi: 10.1016/j.jaip.2013.11.006. J Allergy Clin Immunol Pract. 2014. PMID: 24565763 Review.
-
Recent advances in the diagnosis of drug allergy.Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):299-303. doi: 10.1097/ACI.0b013e328216f4d4. Curr Opin Allergy Clin Immunol. 2007. PMID: 17620820 Review.
Cited by
-
Penicillin allergy de-labeling: Adaptation of risk stratification tool for patients and families.World Allergy Organ J. 2024 Jul 23;17(8):100939. doi: 10.1016/j.waojou.2024.100939. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39156596 Free PMC article.
-
Risk factors for drug hypersensitivity reactions in children.Ital J Pediatr. 2024 Jul 15;50(1):127. doi: 10.1186/s13052-024-01694-x. Ital J Pediatr. 2024. PMID: 39010141 Free PMC article. Review.
-
True Rate of Allergy among Pediatric Inpatients with Penicillin Allergy Labels (TRIAL).Can J Hosp Pharm. 2024 Jul 10;77(3):e3531. doi: 10.4212/cjhp.3531. eCollection 2024. Can J Hosp Pharm. 2024. PMID: 38988874
-
How to Define and Manage Low-Risk Drug Allergy Labels.J Allergy Clin Immunol Pract. 2024 May;12(5):1095-1106. doi: 10.1016/j.jaip.2024.03.021. J Allergy Clin Immunol Pract. 2024. PMID: 38724164 Free PMC article. Review.
-
Beta-Lactam Allergy De-labeling in a Pediatric Hospital.J Pediatr Pharmacol Ther. 2024 Apr;29(2):169-174. doi: 10.5863/1551-6776-29.2.169. Epub 2024 Apr 8. J Pediatr Pharmacol Ther. 2024. PMID: 38596425 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
